Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Viveve Medical, Inc.

Viveve to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 11, 2022
From Viveve Medical, Inc.
Via AccessWire
Tickers VIVE
Viveve Announces Expansion of IP Portfolio with Patent Issuance in Taiwan
From Viveve Medical, Inc.
Via AccessWire
Topics Intellectual Property
Tickers VIVE
Viveve to Participate in H.C. Wainwright Global Investment Conference
From Viveve Medical, Inc.
Via AccessWire
Tickers VIVE
Viveve CEO Scott Durbin Named Among Top 50 Healthcare Technology Leaders of 2022 by Healthcare Technology Report
From Viveve Medical, Inc.
Via AccessWire
Tickers VIVE
Viveve Reports First Quarter 2022 Financial Results and Provides Corporate Update
From Viveve Medical, Inc.
Via AccessWire
Tickers VIVE
Viveve to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 12, 2022
From Viveve Medical, Inc.
Via AccessWire
Tickers VIVE
Viveve Reports Full Year 2021 Financial Results and Provides Corporate Update
From Viveve Medical, Inc.
Via AccessWire
Tickers VIVE
Viveve to Report Full Year 2021 Financial Results and Provide Corporate Update on March 17, 2022
From Viveve Medical, Inc.
Via AccessWire
Tickers VIVE
Healthcare Technology Report Names Viveve Regulatory Executive Among Top 25 Women Leaders in Medical Devices
From Viveve Medical, Inc.
Via AccessWire
Tickers VIVE
Viveve to Participate in H.C. Wainwright BIOCONNECT Conference
From Viveve Medical, Inc.
Via AccessWire
Tickers VIVE
Viveve Announces Completion of Full Enrollment in Pivotal U.S. PURSUIT Trial for Stress Urinary Incontinence
From Viveve Medical, Inc.
Via AccessWire
Tickers VIVE
Viveve Reports Third Quarter 2021 Financial Results and Provides Corporate Update
From Viveve Medical, Inc.
Via AccessWire
Topics Intellectual Property
Tickers VIVE
Viveve to Host Conference Call on November 11, 2021 to Report Third Quarter Financial Results and Provide Corporate Update
From Viveve Medical, Inc.
Via AccessWire
Tickers VIVE
Viveve Announces Issuance of New Device and Methods Patent in U.S
From Viveve Medical, Inc.
Via AccessWire
Topics Intellectual Property
Tickers VIVE
Viveve Announces Issuance of New Method Patent for Stress Urinary Incontinence in Australia
From Viveve Medical, Inc.
Via AccessWire
Topics Intellectual Property
Tickers VIVE
Viveve to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
From Viveve Medical, Inc.
Via AccessWire
Tickers VIVE
Viveve Reports Second Quarter 2021 Financial Results and Provides Corporate Update
From Viveve Medical, Inc.
Via AccessWire
Topics Intellectual Property
Tickers VIVE
Viveve to Host Conference Call on August 12, 2021 to Report Second Quarter Financial Results and Provide Corporate Update
From Viveve Medical, Inc.
Via AccessWire
Tickers VIVE
Viveve Announces Continued Expansion of IP Portfolio with Issuance of Canadian Patent
From Viveve Medical, Inc.
Via AccessWire
Topics Intellectual Property
Tickers VIVE
Viveve Announces New Category III CPT Code for its Stress Urinary Incontinence Procedure
From Viveve Medical, Inc.
Via AccessWire
Tickers VIVE
Viveve to Participate in Ladenburg Thalmann Healthcare Virtual Conference
From Viveve Medical, Inc.
Via AccessWire
Tickers VIVE
Viveve Announces Issuance of New Device and Methods Patent in U.S.
From Viveve Medical, Inc.
Via AccessWire
Topics Intellectual Property
Tickers VIVE
Viveve Announces Adjournment of Annual Meeting
From Viveve Medical, Inc.
Via AccessWire
Tickers VIVE
Viveve Reports First Quarter 2021 Financial Results and Provides Corporate Update
From Viveve Medical, Inc.
Via AccessWire
Topics Intellectual Property
Tickers VIVE
Viveve Announces Adjournment of Annual Meeting
From Viveve Medical, Inc.
Via AccessWire
Tickers VIVE
Viveve To Host Conference Call on May 13, 2021 To Report First Quarter Financial Results and Provide Corporate Update
From Viveve Medical, Inc.
Via AccessWire
Tickers VIVE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.